17 Healthcare Stocks Moving In Friday's Pre-Market Session

Gainers

Therapix Biosciences, Inc. TRPX shares rose 23.27% to $0.59 during Friday's pre-market session.

Pluristem Therapeutics, Inc. PSTI shares rose 20.26% to $10.21.

Sesen Bio, Inc. SESN stock rose 11.92% to $0.80.

Redhill Biopharma, Inc. RDHL stock increased by 10.70% to $7.24. The most recent rating by H.C. Wainwright, on Mar 5, is at Buy, with a price target of $14.

KemPharm, Inc. KMPH shares moved upwards by 6.67% to $0.29.

Milestone Pharmaceuticals, Inc. MIST shares moved upwards by 5.68% to $3.35. According to the most recent rating by Jefferies, on Mar 25, the current rating is at Hold.

Arrowhead Pharmaceuticals, Inc. ARWR stock rose 5.47% to $37.05. The most recent rating by Cantor Fitzgerald, on May 8, is at Overweight, with a price target of $58.

Rockwell Medical, Inc. RMTI stock moved upwards by 5.36% to $2.36. The most recent rating by HC Wainwright & Co., on Apr 7, is at Buy, with a price target of $9.

Predictive Oncology, Inc. POAI stock increased by 4.65% to $1.35.

DBV Technologies, Inc. DBVT shares increased by 4.23% to $6.16. The most recent rating by Citigroup, on Apr 6, is at Buy, with a price target of $10.

 

Losers

NantHealth, Inc. NH shares declined 20.56% to $2.28 during Friday's pre-market session.

Tetraphase Pharmaceutical, Inc. TTPH shares decreased by 11.16% to $2.15. According to the most recent rating by Gabelli & Co., on Mar 17, the current rating is at Sell.

Lianluo Smart, Inc. LLIT shares declined 8.25% to $0.44.

Agile Therapeutics, Inc. AGRX stock fell 5.74% to $2.30. The most recent rating by H.C. Wainwright, on Mar 20, is at Buy, with a price target of $6.

Biomerica, Inc. BMRA stock fell 4.42% to $7.13.

Titan Pharmaceuticals, Inc. TTNP shares declined 3.95% to $0.31.

Cocrystal Pharma, Inc. COCP stock decreased by 3.23% to $0.90.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Pre-Market OutlookMarketsMoversTrading IdeasHealthcare Stocks Pre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!